| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/MC.20688 |
| P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmc.20688 |
| https://onlinelibrary.wiley.com/doi/pdf/10.1002/mc.20688 | ||
| P698 | PubMed publication ID | 21061265 |
| P2093 | author name string | Anas Younes | |
| Carol J. Etzel | |||
| Sara S. Strom | |||
| Anthony M. D'Amelio | |||
| Mirtha S. Lopez | |||
| Randa A. El-Zein | |||
| Claudia M. Monroy | |||
| Andrea C. Cortes | |||
| P2860 | cites work | Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma | Q23909513 |
| A new look at the statistical model identification | Q26778401 | ||
| Cyclooxygenases in cancer: progress and perspective | Q28213081 | ||
| Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer | Q33951229 | ||
| The evolution of gene duplicates | Q34586458 | ||
| Cyclooxygenase-2 Biology | Q35551907 | ||
| Common gene polymorphisms, cancer progression and prognosis | Q35754435 | ||
| GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells | Q35834668 | ||
| Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma | Q35848263 | ||
| Molecular epidemiology, cancer-related symptoms, and cytokines pathway | Q36079191 | ||
| GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors | Q36391825 | ||
| Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma | Q36447972 | ||
| Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era | Q36915855 | ||
| Association of single nucleotide polymorphisms in the IL-18 gene with production of IL-18 protein by mononuclear cells from healthy donors. | Q36943865 | ||
| Cytokines as a key component of cancer-related inflammation | Q37243051 | ||
| The biology of Hodgkin's lymphoma | Q37349652 | ||
| Monitoring of IL-10 in the serum of patients with advanced ovarian cancer: results from a prospective pilot-study | Q40019673 | ||
| Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes | Q40687886 | ||
| Cytokine function: a study in biologic diversity | Q40982864 | ||
| Characterization of anti-human interleukin-18 (IL-18)/interferon-gamma-inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL-18 by ELISA. | Q41094643 | ||
| Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer | Q44781880 | ||
| Inhibition of IL-6, TNF-alpha, and cyclooxygenase-2 protein expression by prostaglandin E2-induced IL-10 in bone marrow-derived dendritic cells | Q44953132 | ||
| The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer. | Q45869240 | ||
| Polymorphisms in the interleukin-10 and interferon gamma genes in Hodgkin lymphoma. | Q51040404 | ||
| Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. | Q51833849 | ||
| Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. | Q52574053 | ||
| Gene expression shift towards normal B cells, decreased proliferative capacity and distinct surface receptors characterize leukemic blasts persisting during induction therapy in childhood acute lymphoblastic leukemia. | Q52927198 | ||
| Expression of IL-10 in Th memory lymphocytes is conditional on IL-12 or IL-4, unless the IL-10 gene is imprinted by GATA-3. | Q52927400 | ||
| Favorable impact of the interleukin-4 receptor allelic variant I75 on the survival of diffuse large B-cell lymphoma patients demonstrated in a large prospective clinical trial. | Q53192906 | ||
| Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma. | Q53510185 | ||
| The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors | Q56902560 | ||
| Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma | Q56903494 | ||
| Clinical Significance of Interleukin-6 (Il-6) Gene Polymorphism and Il-6 Serum Level in Pancreatic Adenocarcinoma and Chronic Pancreatitis | Q60609724 | ||
| Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10(-/-) mice | Q73386832 | ||
| Comparative study on complete remission rate and overall survival in three groups classified based on the serum interleukin-18 level in non-Hodgkin's lymphoma patients | Q73694828 | ||
| Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma | Q75216640 | ||
| Differential expression of chemokines, chemokine receptors, cytokines and cytokine receptors in diffuse large B cell malignant lymphoma | Q75437055 | ||
| MAP kinase pathways as a route for regulatory mechanisms of IL-10 and IL-4 which inhibit COX-2 expression in human monocytes | Q77350544 | ||
| Joint effect between regular use of non-steroidal anti-inflammatory drugs, variants in inflammatory genes and risk of lymphoma | Q79983944 | ||
| Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk | Q80259660 | ||
| Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis | Q80962995 | ||
| Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer | Q81101652 | ||
| IL-2, TNF-alpha, and leptin: local versus systemic concentrations in NSCLC patients | Q81389584 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 36-46 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Molecular Carcinogenesis | Q15724597 |
| P1476 | title | Hodgkin disease risk: role of genetic polymorphisms and gene-gene interactions in inflammation pathway genes | |
| Hodgkin disease risk: Role of genetic polymorphisms and gene–gene interactions in inflammation pathway genes | |||
| P478 | volume | 50 |
| Q47100172 | A Polymorphism Located Near PMAIP1/Noxa Gene Influences Susceptibility to Hodgkin Lymphoma Development in South India |
| Q34643517 | Association between interleukin-4 gene intron 3 VNTR polymorphism and cancer risk |
| Q34997059 | Association of interleukin-18 gene promoter -607 C>A and -137G>C polymorphisms with cancer risk: a meta-analysis of 26 studies |
| Q38370072 | Associations of common IL-4 gene polymorphisms with cancer risk: A meta-analysis |
| Q34984281 | COX-2-765G>C polymorphism increases the risk of cancer: a meta-analysis |
| Q30252147 | Candidate gene association studies and risk of Hodgkin lymphoma: a systematic review and meta-analysis. |
| Q28943266 | Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups |
| Q36822761 | Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients. |
| Q38516259 | Inherited variation in immune response genes in follicular lymphoma and diffuse large B-cell lymphoma |
| Q49555073 | JNK and NF-κB signaling pathways are involved in cytokine changes in patients with congenital heart disease prior to and after transcatheter closure |
| Q37872044 | Predicting treatment outcome in classical Hodgkin lymphoma: genomic advances |
| Q35218562 | Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with high-risk melanoma |
| Q39416564 | The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients |
| Q38407054 | The -137G>C polymorphism in interleukin-18 promoter region and cancer risk: evidence from a meta-analysis of 21 studies |
| Q38097500 | The genetics of innate immunity sensors and human disease |
| Q40160274 | Toll-like receptor 7 Gln11Leu, c.4-151A/G, and +1817G/T polymorphisms in Crimean Congo hemorrhagic fever. |
| Q38238963 | Toll-like receptors in the pathogenesis of human B cell malignancies |
| Q36253844 | Using haplotype analysis to elucidate significant associations between genes and Hodgkin lymphoma |
Search more.